| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
4,429 |
724 |
$1.61M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
21,512 |
15,729 |
$1.37M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
8,608 |
7,536 |
$574K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,305 |
4,366 |
$489K |
| G0381 |
Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
7,859 |
7,276 |
$464K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,775 |
3,265 |
$460K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,519 |
2,215 |
$451K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,950 |
5,591 |
$373K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
13,143 |
10,631 |
$327K |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,007 |
4,067 |
$324K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,173 |
3,422 |
$284K |
| G0378 |
Hospital observation service, per hour |
8,655 |
4,240 |
$270K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,075 |
956 |
$269K |
| G0382 |
Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
3,507 |
3,336 |
$221K |
| 36415 |
Collection of venous blood by venipuncture |
5,920 |
3,673 |
$202K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,936 |
2,316 |
$199K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,322 |
1,119 |
$171K |
| 80053 |
Comprehensive metabolic panel |
35,129 |
24,392 |
$167K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,565 |
1,309 |
$131K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,335 |
2,082 |
$128K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,218 |
3,778 |
$127K |
| G0380 |
Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
2,375 |
2,175 |
$118K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,219 |
1,000 |
$110K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
9,409 |
7,151 |
$94K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,446 |
1,264 |
$88K |
| 82962 |
|
11,625 |
4,632 |
$84K |
| 84484 |
|
12,693 |
7,779 |
$78K |
| 71046 |
Radiologic examination, chest; 2 views |
5,983 |
5,021 |
$68K |
| 85027 |
|
9,254 |
5,616 |
$53K |
| 86850 |
|
1,995 |
1,708 |
$53K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,283 |
647 |
$53K |
| 81025 |
|
9,661 |
8,732 |
$52K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
98 |
63 |
$50K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,342 |
1,050 |
$49K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
34,383 |
24,649 |
$49K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,769 |
4,269 |
$46K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
643 |
502 |
$43K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,018 |
769 |
$42K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,670 |
1,307 |
$42K |
| 85610 |
|
13,691 |
10,271 |
$41K |
| 71045 |
Radiologic examination, chest; single view |
9,674 |
7,677 |
$41K |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
295 |
37 |
$38K |
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
1,652 |
167 |
$37K |
| 87088 |
|
6,876 |
5,972 |
$37K |
| 81001 |
|
12,943 |
11,187 |
$35K |
| 96376 |
|
4,215 |
2,202 |
$32K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
113 |
106 |
$32K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
979 |
909 |
$32K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
14,627 |
11,238 |
$30K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
5,074 |
3,847 |
$29K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,876 |
3,085 |
$28K |
| 85730 |
|
5,249 |
3,922 |
$28K |
| J1644 |
Injection, heparin sodium, per 1000 units |
6,382 |
2,054 |
$27K |
| 84702 |
|
1,927 |
1,620 |
$26K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,454 |
1,315 |
$25K |
| 73562 |
|
633 |
525 |
$24K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
9,823 |
7,597 |
$23K |
| 83735 |
|
5,869 |
3,220 |
$22K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
3,101 |
1,984 |
$21K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,114 |
1,033 |
$20K |
| J1815 |
Injection, insulin, per 5 units |
3,979 |
1,321 |
$20K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,640 |
1,428 |
$20K |
| 81003 |
|
4,100 |
3,532 |
$19K |
| 73630 |
|
336 |
303 |
$19K |
| 72131 |
|
415 |
354 |
$18K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,978 |
2,384 |
$17K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
447 |
392 |
$17K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
156 |
123 |
$17K |
| 73610 |
|
313 |
284 |
$16K |
| 93975 |
|
775 |
721 |
$15K |
| 80061 |
Lipid panel |
2,192 |
1,641 |
$15K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,881 |
2,125 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
404 |
394 |
$14K |
| 73030 |
|
461 |
388 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
809 |
482 |
$14K |
| G0383 |
Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
233 |
179 |
$14K |
| 86900 |
|
2,280 |
1,964 |
$13K |
| 70498 |
|
44 |
38 |
$13K |
| 83880 |
|
2,514 |
1,898 |
$13K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
401 |
380 |
$13K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
642 |
559 |
$12K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
215 |
63 |
$12K |
| 99152 |
|
1,541 |
1,127 |
$12K |
| J2704 |
Injection, propofol, 10 mg |
4,461 |
3,645 |
$11K |
| 93971 |
|
541 |
452 |
$11K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,810 |
1,688 |
$10K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
2,416 |
1,878 |
$9K |
| 99153 |
Mod sedat endo service >5yrs |
998 |
709 |
$9K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
43 |
40 |
$9K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,060 |
1,652 |
$8K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
47 |
39 |
$7K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,535 |
2,008 |
$7K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
280 |
252 |
$7K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,765 |
1,670 |
$7K |
| 73130 |
|
148 |
133 |
$7K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
1,289 |
1,066 |
$7K |
| C1769 |
Guide wire |
507 |
365 |
$7K |
| 76801 |
|
1,216 |
1,053 |
$7K |
| C1776 |
Joint device (implantable) |
21 |
15 |
$6K |
| 86901 |
|
2,407 |
2,048 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,861 |
1,422 |
$6K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
153 |
146 |
$6K |
| 97162 |
|
232 |
192 |
$6K |
| 84703 |
|
1,594 |
1,462 |
$5K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
639 |
471 |
$5K |
| 84100 |
|
2,042 |
843 |
$5K |
| 59025 |
Fetal non-stress test |
162 |
122 |
$5K |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
2,574 |
1,502 |
$5K |
| 83690 |
|
7,383 |
6,359 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,600 |
1,972 |
$5K |
| 93017 |
|
246 |
197 |
$4K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
2,823 |
1,278 |
$4K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
230 |
176 |
$4K |
| 0100U |
|
61 |
59 |
$4K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
38 |
34 |
$4K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
416 |
391 |
$4K |
| 94060 |
|
38 |
29 |
$3K |
| 85379 |
|
2,379 |
2,048 |
$3K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
856 |
685 |
$3K |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
72 |
64 |
$3K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
151 |
136 |
$3K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,930 |
1,508 |
$3K |
| 82565 |
|
107 |
83 |
$3K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
55 |
49 |
$3K |
| 87186 |
|
1,905 |
1,560 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,402 |
5,162 |
$2K |
| 87070 |
|
314 |
262 |
$2K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
378 |
262 |
$2K |
| 76830 |
Ultrasound, transvaginal |
491 |
460 |
$2K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
38 |
29 |
$2K |
| 80320 |
|
800 |
690 |
$2K |
| 74018 |
|
142 |
127 |
$2K |
| 73110 |
|
48 |
43 |
$2K |
| 72100 |
|
30 |
28 |
$2K |
| 87077 |
|
1,245 |
1,023 |
$2K |
| 87205 |
|
337 |
278 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,112 |
1,032 |
$2K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
417 |
281 |
$2K |
| 84145 |
|
399 |
305 |
$1K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
48 |
37 |
$1K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
537 |
425 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
15 |
14 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
13 |
$1K |
| J2785 |
Injection, regadenoson, 0.1 mg |
53 |
41 |
$1K |
| 88312 |
|
679 |
542 |
$1K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
455 |
398 |
$1K |
| 83605 |
|
994 |
666 |
$1K |
| 87486 |
|
447 |
392 |
$1K |
| 87581 |
|
447 |
392 |
$1K |
| 90715 |
|
112 |
100 |
$1K |
| 87807 |
|
12 |
12 |
$1K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
939 |
714 |
$1K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
195 |
141 |
$1K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
16 |
14 |
$1K |
| 87040 |
|
629 |
411 |
$977.39 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
86 |
64 |
$972.79 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
850 |
682 |
$970.96 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,312 |
1,025 |
$872.57 |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
14 |
12 |
$870.13 |
| 72128 |
|
168 |
148 |
$814.99 |
| 87081 |
|
595 |
517 |
$810.12 |
| 88304 |
|
87 |
76 |
$807.22 |
| 73502 |
|
71 |
50 |
$792.94 |
| 93458 |
|
36 |
26 |
$762.13 |
| 70486 |
|
33 |
30 |
$730.55 |
| 82728 |
|
109 |
93 |
$728.98 |
| 85007 |
|
1,076 |
823 |
$722.65 |
| 70496 |
|
35 |
30 |
$703.75 |
| 87210 |
|
617 |
579 |
$660.44 |
| 71250 |
|
35 |
30 |
$537.85 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
699 |
650 |
$523.11 |
| 82550 |
|
667 |
528 |
$510.43 |
| J3480 |
Injection, potassium chloride, per 2 meq |
55 |
39 |
$493.93 |
| 83540 |
|
282 |
244 |
$422.70 |
| J2060 |
Injection, lorazepam, 2 mg |
1,077 |
756 |
$406.75 |
| 84132 |
|
84 |
51 |
$403.73 |
| 82805 |
|
41 |
29 |
$393.91 |
| 85652 |
|
149 |
128 |
$348.09 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
525 |
512 |
$315.24 |
| 90686 |
|
14 |
13 |
$309.95 |
| 88313 |
|
61 |
40 |
$309.34 |
| 82607 |
|
299 |
239 |
$292.89 |
| 00731 |
|
452 |
379 |
$259.41 |
| 82746 |
|
65 |
50 |
$250.00 |
| 00813 |
|
299 |
273 |
$229.94 |
| 87507 |
|
32 |
30 |
$223.38 |
| 83550 |
|
258 |
226 |
$213.70 |
| 96368 |
|
94 |
79 |
$177.33 |
| 51701 |
|
199 |
152 |
$175.84 |
| 29530 |
|
13 |
12 |
$90.00 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
83 |
71 |
$90.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
250 |
134 |
$80.79 |
| 94729 |
|
85 |
65 |
$65.45 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
139 |
118 |
$45.69 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
14 |
13 |
$40.67 |
| 86140 |
|
171 |
138 |
$34.62 |
| 88307 |
|
35 |
26 |
$24.80 |
| 82330 |
|
106 |
92 |
$20.38 |
| J1756 |
Injection, iron sucrose, 1 mg |
112 |
50 |
$12.71 |
| 83615 |
|
46 |
34 |
$2.95 |
| 94727 |
|
34 |
28 |
$0.00 |
| 83970 |
|
114 |
95 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
13 |
12 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
380 |
266 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
38 |
30 |
$0.00 |
| 00840 |
|
81 |
69 |
$0.00 |
| 29125 |
|
55 |
49 |
$0.00 |
| C1876 |
Stent, non-coated/non-covered, with delivery system |
43 |
31 |
$0.00 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
30 |
27 |
$0.00 |
| Q9950 |
Injection, sulfur hexafluoride lipid microspheres, per ml |
109 |
51 |
$0.00 |
| 82248 |
|
15 |
14 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
23 |
14 |
$0.00 |
| 96367 |
|
19 |
13 |
$0.00 |
| 85384 |
|
23 |
17 |
$0.00 |
| 84550 |
|
24 |
18 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
12 |
12 |
$0.00 |
| J1270 |
Injection, doxercalciferol, 1 mcg |
548 |
67 |
$0.00 |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
62 |
45 |
$0.00 |
| 88342 |
|
44 |
43 |
$0.00 |
| 80329 |
|
70 |
67 |
$0.00 |
| 97166 |
|
18 |
13 |
$0.00 |
| 80069 |
|
91 |
48 |
$0.00 |
| 00790 |
|
16 |
12 |
$0.00 |
| 87147 |
|
16 |
13 |
$0.00 |